Literature DB >> 9737691

Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.

K W Maloney1, L McGavran, L F Odom, S P Hunger.   

Abstract

The p16INK4A (p16) and p15INK4B (p15) tumor suppressor genes are inactivated by homozygous gene deletion and p15 promoter hypermethylation in a significant proportion of childhood acute lymphoblastic leukemias (ALLs). However, little is known about the potential association between p16/p15 gene alterations and specific genetic abnormalities implicated in leukemogenesis. The t(1;19)(q23;p13) and t(17;19)(q21-22;p13) are non-random translocations observed in childhood ALL that create distinct E2A fusion proteins: E2A-PBX1 and E2A-HLF, respectively. Previously, a negative association was found between the t(1;19) and homozygous p16/p15 deletions. In this study we determined p16 and p15 gene status in additional t(1;19)+ ALLs and compared this incidence to that observed in t(17;19)+ ALLs. No homozygous p16 or p15 deletions were observed among 13 t(1;19)+ ALLs analyzed. In contrast, homozygous deletions of both p16 and p15 were present in two of four t(17;19)+ ALLs. None of 10 t(1;19)+ ALLs contained p15 promoter hypermethylation. In contrast, one of the two t(17;19)+ ALLs that lacked p15/p16 homozygous deletions showed probable hemizygous p15 hypermethylation. We conclude that homozygous p16 and/or p15 deletions and p15 hypermethylation rarely accompany E2A-PBX1 fusion, but occur in concert with E2A-HLF fusion in a subset of t(17;19)+ ALLs. These findings suggest that there may be different modes of cooperative leukemogenesis in ALLs associated with different E2A fusion proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737691     DOI: 10.1038/sj.leu.2401124

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Identification of cyclin D3 as a direct target of E2A using DamID.

Authors:  Siyuan Song; Jonathan Cooperman; Danielle L Letting; Gerd A Blobel; John Kim Choi
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 2.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

3.  Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.

Authors:  Kevin S Smith; Joon Whan Rhee; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.

Authors:  Charles G Mullighan; Cheryl L Willman
Journal:  J Adolesc Young Adult Oncol       Date:  2011-06       Impact factor: 2.223

5.  Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.

Authors:  Christofer Diakos; Yuanyuan Xiao; Shichun Zheng; Leo Kager; Michael Dworzak; Joseph L Wiemels
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 6.  The functional role of long non-coding RNAs and epigenetics.

Authors:  Jinneng Cao
Journal:  Biol Proced Online       Date:  2014-09-15       Impact factor: 3.244

Review 7.  Long non-coding RNAs: Mechanism of action and functional utility.

Authors:  Shakil Ahmad Bhat; Syed Mudasir Ahmad; Peerzada Tajamul Mumtaz; Abrar Ahad Malik; Mashooq Ahmad Dar; Uneeb Urwat; Riaz Ahmad Shah; Nazir Ahmad Ganai
Journal:  Noncoding RNA Res       Date:  2016-11-12

Review 8.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.